MeSH term
Frequency | Condition_Probility | Animals | 55 | 0.0 |
Humans | 107 | 0.0 |
3' Untranslated Regions/*genetics | 3 | 8.0 |
Adult | 24 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 4 | 0.0 |
Comparative Study | 9 | 0.0 |
DNA/genetics | 2 | 0.0 |
Female | 33 | 0.0 |
Infant | 3 | 0.0 |
Male | 35 | 0.0 |
Middle Aged | 22 | 0.0 |
Muscle, Skeletal/enzymology/*pathology | 2 | 40.0 |
Protein-Serine-Threonine Kinases/*genetics | 24 | 8.0 |
Research Support, Non-U.S. Gov't | 87 | 0.0 |
*Trinucleotide Repeat Expansion | 6 | 13.0 |
Base Sequence | 24 | 0.0 |
Brain/metabolism | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
Mice | 31 | 0.0 |
Mice, Knockout | 8 | 0.0 |
Molecular Sequence Data | 24 | 0.0 |
Muscle, Skeletal/metabolism | 5 | 2.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Myotonic Dystrophy/*genetics/pathology | 6 | 75.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Transfection | 6 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Myotonic Dystrophy/*genetics | 26 | 40.0 |
Nuclear Proteins/*genetics/metabolism | 2 | 1.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Trinucleotide Repeat Expansion/*genetics | 7 | 11.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
Genotype | 4 | 0.0 |
Reference Values | 3 | 0.0 |
Trinucleotide Repeats/*genetics | 9 | 11.0 |
*Gene Expression Regulation | 4 | 0.0 |
Trinucleotide Repeat Expansion | 4 | 11.0 |
Drug Evaluation, Preclinical/*methods | 3 | 9.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Cells, Cultured | 15 | 0.0 |
Electromyography | 3 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Gene Expression | 6 | 0.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Mice, Transgenic | 10 | 0.0 |
Myotonic Dystrophy/genetics/pathology | 2 | 100.0 |
Phenotype | 7 | 0.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
Trinucleotide Repeats/genetics | 3 | 4.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
*Trinucleotide Repeats | 12 | 10.0 |
COS Cells | 5 | 0.0 |
Mutation | 15 | 0.0 |
Myotonic Dystrophy/genetics | 4 | 28.0 |
Protein Isoforms | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*biosynthesis/genetics | 3 | 13.0 |
Tissue Distribution | 6 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Blotting, Western | 8 | 0.0 |
Cell Division | 3 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Muscle, Skeletal/*metabolism/pathology | 2 | 12.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Homeodomain Proteins/biosynthesis/*genetics | 2 | 9.0 |
Mutation/genetics | 2 | 0.0 |
Nucleic Acid Conformation | 2 | 0.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Absorption | 2 | 1.0 |
Chemistry, Physical | 2 | 1.0 |
Computer Simulation | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
In Vitro | 4 | 0.0 |
Models, Biological | 3 | 0.0 |
Pharmaceutical Preparations/*metabolism | 4 | 4.0 |
*Pharmacokinetics | 2 | 4.0 |
Protein Binding | 7 | 0.0 |
Technology, Pharmaceutical/*methods/*trends | 2 | 100.0 |
Biopsy | 4 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Muscle, Skeletal/enzymology | 2 | 4.0 |
Myotonic Dystrophy/*enzymology/genetics | 2 | 100.0 |
RNA, Messenger/*metabolism | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Alleles | 8 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Cell Line | 8 | 0.0 |
*DNA Methylation | 2 | 0.0 |
Homeodomain Proteins/genetics | 7 | 3.0 |
Protein-Serine-Threonine Kinases/genetics | 11 | 8.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
3' Untranslated Regions/genetics | 7 | 7.0 |
Fibroblasts | 2 | 0.0 |
RNA-Binding Proteins/genetics/*metabolism | 3 | 4.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Binding Sites | 3 | 0.0 |
DNA Primers/genetics | 4 | 0.0 |
Myotonic Dystrophy/*enzymology | 2 | 100.0 |
Phosphorylation | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Protein Kinases/genetics | 3 | 5.0 |
Pedigree | 10 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 3 | 1.0 |
Brain/*enzymology | 2 | 1.0 |
Protein-Serine-Threonine Kinases/*metabolism | 5 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Ribonucleoproteins/*metabolism | 2 | 4.0 |
*Ion Channel Gating | 2 | 12.0 |
Patch-Clamp Techniques | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics/metabolism | 5 | 8.0 |
DNA/metabolism | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Hela Cells | 4 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Gene Library | 4 | 0.0 |
Myocardium/*metabolism | 2 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Electrocardiography | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Myotonic Dystrophy/enzymology/*genetics | 7 | 70.0 |
Infant, Newborn | 4 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Exons | 3 | 0.0 |
Aged | 9 | 0.0 |
Family Health | 2 | 0.0 |
Haplotypes | 5 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Trinucleotide Repeats | 4 | 3.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
RNA-Binding Proteins/genetics | 2 | 3.0 |
Myotonic Dystrophy/genetics/*metabolism | 2 | 66.0 |
Rabbits | 2 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Cell Fusion | 2 | 0.0 |
Genes, Reporter | 3 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 5 | 1.0 |
Models, Genetic | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Age Factors | 2 | 0.0 |
Heart/physiology | 2 | 5.0 |
Rats | 4 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Trinucleotide Repeat Expansion/genetics | 3 | 7.0 |
English Abstract | 3 | 0.0 |
Protein Kinases/*genetics | 5 | 4.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Fetus/enzymology | 2 | 7.0 |
Minisatellite Repeats | 2 | 1.0 |
Chromosomes, Human, Pair 19/genetics | 2 | 1.0 |
Genes, Dominant | 3 | 0.0 |
*Protein-Serine-Threonine Kinases | 3 | 0.0 |
Myocardium/metabolism | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Cell Fractionation | 2 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
RNA/genetics/metabolism | 2 | 1.0 |
RNA, Messenger | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Homozygote | 3 | 0.0 |
Adolescent | 5 | 0.0 |
Chromosomes, Human, Pair 19 | 3 | 1.0 |
*Mutation | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 3 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Time Factors | 2 | 0.0 |
